Children With Aluminium Contact Allergy: Oral Exposure Study
NCT ID: NCT04921163
Last Updated: 2023-03-28
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
15 participants
INTERVENTIONAL
2021-06-01
2022-06-15
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
The Feasibility of Systemic Reaction After Contact Exposure to the Allergenic Food in Children With Known Food Allergy
NCT05080127
Non Celiac Gluten Sensitivity, DBPCFC in Adolescents
NCT04639921
Integrated Approaches to Food Allergen and Allergy Risk Management
NCT02295397
Persistence of Oral Tolerance to Peanut
NCT01366846
Immunologic Profile of Children With Severe Allergies to Peanuts and Nuts After Induction of Tolerance
NCT01996774
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Children are predominantly exposed to aluminium via the diet as they do not yet use aluminium-containing cosmetic products, stomach acid medicines or deodorants. The amount of aluminium in children's diet varies between 0.22-0.90 mg/kg body weight/week, depending on their age. In older children and adults, the intake is less related to the aluminium in infant formula, breakfast cereals and dried fruit, which is consumed more by children than adults.
With this study, we want to create an exposure study where children have to eat pancakes for a limited period of time, where aluminium has been used as baking soda, and for two control periods eat pancakes without aluminium.
Any symptoms occurring during periods could be used to investigate whether children with aluminium allergies generally react after intake of aluminium-containing foods and whether as such it is a consequential condition in some children or whether it is isolated cases. It is a very important issue to clarify with a view to proper advice, both with regard to the possible avoidance of specific foods and in the case of future vaccinations.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
BASIC_SCIENCE
TRIPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
aluminium
4-day test periode with intake of aluminium pancakes
sodium aluminium phospate (SALP)
1 pancake daily for 4 days
placebo
4-day test periode with aluminium-free pancakes
Aluminium-free pancake
1 pancake daily for 4 days, without aluminium
second placebo
Again a 4-day test periode with aluminium-free pancakes
Aluminium-free pancake
1 pancake daily for 4 days, without aluminium
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
sodium aluminium phospate (SALP)
1 pancake daily for 4 days
Aluminium-free pancake
1 pancake daily for 4 days, without aluminium
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Activity (itching) of the granulom within the last six months
* Written consent obtained from all custodians
Exclusion Criteria
* Children treated with topical and/or systemic steroid preparations during and up to 1 week before the start of the study.
* Children treated with systemic immune suppression during and up to 1 week before the start of the study.
* Children with kidney or bone disease.
* Children vaccinated during the study period
* Treatment with acid neutralising medicines during and up to 1 week before the start of the study
* Another reason for inability to cooperate, including lack of language skills in Danish or English in parents.
1 Year
12 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
National Allergy Research Center, Denmark
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Stine Hoffmann
MD, ph.d. student
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
National Allergy Research Centre
Hellerup, , Denmark
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
H-20060917
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.